Sample Pooling and Inflammation Linked to the False Selection of Biomarkers for Neurodegenerative Diseases in Top–Down Proteomics: A Pilot Study
Proteomic technologies have been recently adapted to the new field of clinical proteomics. The origin of errors and biases has been well-identified in the pre-analytical steps, leading to the measurement of clinical analytes. One possible source of inadequacy in clinical proteomics is linked to samp...
Main Authors: | Nicolas Molinari, Stéphane Roche, Katell Peoc’h, Laurent Tiers, Martial Séveno, Christophe Hirtz, Sylvain Lehmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnmol.2018.00477/full |
Similar Items
-
Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
by: Olivia Belbin, et al.
Published: (2020-11-01) -
It is time for top-down venomics
by: Rafael D. Melani, et al.
Published: (2017-10-01) -
Fabrication top-down, caractérisation et applications de nanofils silicium
by: Vaurette, François
Published: (2008) -
Top-Down Causation and the Rise of Information in the Emergence of Life
by: Sara Imari Walker
Published: (2014-07-01) -
Toy Models of Top Down Causation
by: Adrian Kent
Published: (2020-10-01)